Search results
Found 7187 matches for
Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.
Amber Thompson
Amber Thompson - Senior QA and Sample Compliance Manager
Emma Plested
Emma Plested - Programme and Regulatory Affairs Director (UK)
Sarah Kelly
MSc Sarah Kelly - Clinical Programme Director (Global)
Sir Andrew Pollard
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity
Jennifer Lawson
BSc, MSc Jennifer Lawson - Senior Programme Manager